Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients

Purpose

The purpose of this study is to determine the safety and effectiveness of the study drug, GSK249320, an experimental new drug not yet approved for treatment of patients who have had a stroke. Phone: 904-244-9514 Email: Nader.antonios@jax.ufl.edu

Keywords

safety, drug, stroke, comparison

Principal Investigator

NADER ANTONIOS, CLINICAL ASSISTANT PROFESSOR

Department

JAX NEUROLOGY

Contact Information

Nader.antonios@jax.ufl.edu
(904) 244-9514

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams